Alternative therapy use in neurologic diseases use in brain tumor patients

Neurology

Volumn 52, Issue 3, 1999, Pages 617-622

  Verhoef, Marja J ^a,d   Hagen, Neil ^b,c   Pelletier, Guy ^c   Forsyth, Peter ^b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c TOM BAKER CANCER CENTRE   (Canada)

^d NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUPUNCTURE; ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; BRAIN TUMOR; CANCER ADJUVANT THERAPY; FEMALE; HEALTH CARE DELIVERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MASSAGE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME; WELLBEING;

EID: 0033015921     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.3.617     Document Type: Article

References (29)

1. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Alternative medicine in the United States. Prevalence, costs and patterns of use. N Engl J Med 1993;328:246-252.
2. Cassileth BR, Lusk EJ, Strouse TB, Bodenheimer BJ. Contemporary unorthodox treatments in cancer medicine. A study of patients, treatments and practitioners. Ann Intern Med 1984;101:105-112.
3. Sollner W, Zingg-Schir M, Rumpold G, Fritsch P. Attitude toward alternative therapy, compliance with standard treatment, and need for emotional support in patients with melanoma. Arch Dermatol 1997;133:316-321.
4. Lerner IJ, Kennedy BJ. The prevalence of questionable methods of cancer treatment in the United States. CA Cancer J Clin 1992;42:181-191.
5. Risberg T, Kaasa S, Wist E, Melsom H. Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway. Eur J Cancer 1997;33: 575-580.
6. Begbie SD, Kerestes ZL, Bell DR. Patterns of alternative medicine use by cancer patients. MJA 1996;165:545-548.
7. Munstedt K, Kirsch K, Milch W, Sachsse S, Vahrson H. Alternative cancer therapy - survey of patients with gynecological malignancy. Arch Gynecol Obstet 1996;258:81-88.
8. Murray RH, Rubel AJ. Physicians and healers - unwilling partners in health care. N Engl J Med 1992;326:61-64.
9. Hogan DB, Ebly EM. Complementary medicine use in a dementia clinic population. Alzheimer Dis Assoc Disord 1996;10: 63-67.
10. Coleman LM, Fowler LL, Williams ME. Use of unproven therapies by people with Alzheimer's disease. J Am Geriatr Soc 1995;43:747-750.
11. Fawcett J, Sidney JS, Riley-Lawless K, Hanson MJ. An exploratory study of the relationship between alternative therapies, functional status, and symptom severity among people with multiple sclerosis. J Holist Nurs 1996;14:115-129.
12. Danesi MA, Adetunji JB. Use of alternative medicine by patients with epilepsy: a survey of 265 epileptic patients in a developing country. Epilepsia 1994;35:344-351.
13. MacGregor EA, Vohrah C, Wilkinson M. Analgesic use: a study of treatments used by patients for migraine prior to attending the City of London Migraine Clinic. Headache 1990; 30:571-574.
14. Evans RW, Evans RI, Sharp MJ. The physician survey on the post-concussion and whiplash syndromes. Headache 1994;34: 268-274.
15. Bagenal F, Easton D, Harris E, Chilvers CE, McElwain TJ. Survival of patients with breast cancer attending Bristol Cancer Help Centre. Lancet 1990;336:606-610.
16. Moertel CG, Fleming TR, Rubin J, et al. A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. N Engl J Med 1982;306:201-206.
17. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989;2:888-891.
18. Chlebowski RT, Bulcavage L, Grosvenor M, et al. Hydrazine sulfate influence on nutritional status and survival in nonsmall-cell lung cancer. J Clin Oncol 1990;8:9-15.
19. Loprinzi CL, Kuross SA, O'Fallon JR, et al. Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer. J Clin Oncol 1994;12:1121-1125.
20. Cassileth BR, Lusk EJ, Duport G, et al. Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. N Engl J Med 1991;324:1180-1185.
21. Capobianco DJ, Brazis PW, Fox TP. Proximal muscle weakness induced by herbs. N Engl J Med 1993;329:1430. Letter.
22. Larrey D, Vial T, Pauwels A, et al. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatoxicity. Ann Intern Med 1992;117:129-132.
23. Verhoef MJ, Sutherland LR, Brkich L. Use of alternative medicine by patients attending a gastroenterology clinic. Can Med Assoc J 1990;142:121-125.
24. Sutherland LR, Verhoef MJ. Alternative medicine consultation by patients attending a multidisciplinary HIV clinic. AIDS Patient Care 1995;9:106-111.
25. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570-579.
26. Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA. The Functional Assessment of Cancer Therapy (FACT) scale. Cancer 1995;75:1151-1161.
27. Creswell JW. Research design. Qualitative and quantitative approaches. Thousand Oaks, CA: Sage Publications, 1994.
28. Forsyth P, Cairncross G, Stewart D, Goodyear H, Wainman N, Eisenhauer E. Phase II trial of docetaxel in patients with recurrent malignant glioma: a study of the National Cancer Institute of Canada Clinical Trials Group. Invest New Drugs 1996;14:203-206.
29. Hagen NA, Whylie B. Putting clinical practice guidelines into the hands of cancer patients. Can Med Assoc J 1998;158: 347-348.